![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Ligand to Acquire Neurogen for Stock, Contingent Value Rights
Ligand to Acquire Neurogen for Stock, Contingent Value Rights
August 24, 2009
Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced Monday they have entered into a definitive merger agreement under which Ligand will acquire Neurogen.
Earth Times
Earth Times
Upcoming Events
-
21Oct